VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2019/12/13	07:15	PR Newswire (US)	Mihael H. Polymeropoulos, MD, President and CEO of Vanda Pharmaceuticals Inc., to Receive The Physicians Committee for Respon...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/11/19	06:01	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at November 2019 Investor Conferences	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/11/07	21:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/11/07	06:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/11/07	06:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Third Quarter 2019 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/10/31	05:30	PR Newswire (US)	Vanda Pharmaceuticals to Announce Third Quarter 2019 Financial Results on November 6, 2019	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/10/29	05:56	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/10/29	05:30	PR Newswire (US)	Vanda Pharmaceuticals Appoints Anne Sempowski Ward to Board of Directors	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/10/24	05:01	PR Newswire (US)	Vanda Announces New Study Results Showing a High Degree of Inbreeding in Beagle Dogs	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/10/17	05:01	PR Newswire (US)	Vanda Applauds White House Issuance of Executive Orders Requiring Federal Agencies to be Transparent in Policymaking and Enfo...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/09/12	06:20	PR Newswire (US)	Vanda Pharmaceuticals Applauds the EPA's Landmark Commitment to Eliminate Animal Testing and Urges the Food and Drug Administ...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/29	05:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/22	05:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/22	05:49	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/22	05:46	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/21	20:00	PR Newswire (US)	Vanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketin...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/19	20:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/19	20:00	PR Newswire (US)	Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/16	05:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/01	20:05	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/01	05:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/08/01	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Second Quarter 2019 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/07/23	05:01	PR Newswire (US)	Vanda Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/07/22	21:35	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/07/22	20:00	PR Newswire (US)	Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/07/17	06:25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/07/17	05:15	PR Newswire (US)	Tradipitant Effective in Preventing Motion Sickness	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/06/25	05:59	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/06/18	22:50	PR Newswire (US)	Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/06/18	06:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc